COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

Autor: Xose L. Perez-Fernandez, John R. Prowle, Shruti Gupta, John A. Kellum, Kianoush Kashani, Nattachai Srisawat, Ashita Tolwani, Faeq Husain-Syed, Nuttha Lumlertgul, Li Yang, Mitra K. Nadim, Claudio Ronco, Matthieu Legrand, Eric Hoste, Thiago Reis, Gianluca Villa, Kathleen D. Liu, Jay L. Koyner, Michael Joannidis, Peter Pickkers, Stuart L. Goldstein, Neesh Pannu, Marlies Ostermann, Sumit Mohan, Lui G. Forni, Zhiyong Peng, Michael J. Germain, Thomas Rimmelé, Ravindra L. Mehta, Vincenzo Cantaluppi, Anitha Vijayan, Michael J. Connor, Azra Bihorac, Alexander Zarbock, Samira Bell
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Kidney Disease
Scientific community
medicine.medical_treatment
030232 urology & nephrology
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
CORONAVIRUS
Disease
urologic and male genital diseases
Acute renal failure
0302 clinical medicine
Risk Factors
INFECTION
Medicine and Health Sciences
030212 general & internal medicine
RENAL-REPLACEMENT THERAPY
PERITONEAL-DIALYSIS
Proteinuria
Acute kidney injury
Acute Kidney Injury
Urology & Nephrology
female genital diseases and pregnancy complications
Renal Replacement Therapy
Insuficiència renal aguda
Nephrology
Infectious diseases
medicine.symptom
CRITICALLY-ILL PATIENTS
medicine.medical_specialty
Consensus
POLYMYXIN-B HEMOPERFUSION
Clinical Sciences
Renal and urogenital
Peritoneal dialysis
03 medical and health sciences
medicine
Humans
Renal replacement therapy
Risk factor
Intensive care medicine
Dialysis
Septic shock
business.industry
urogenital system
SARS-CoV-2
Prevention
SEPTIC SHOCK
Consensus Statement
Anticoagulants
COVID-19
medicine.disease
BALANCED CRYSTALLOIDS
business
Zdroj: Nature Reviews. Nephrology
Nature Reviews. Nephrology, 16, 12, pp. 747-764
Nature Reviews Nephrology
Nature Reviews. Nephrology, 16, 747-764
Dipòsit Digital de la UB
Universidad de Barcelona
Nature reviews. Nephrology, vol 16, iss 12
NATURE REVIEWS NEPHROLOGY
ISSN: 1759-507X
1759-5061
Popis: Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional ‘surges’ in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.
COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and is an independent risk factor for all-cause in-hospital death in patients with COVID-19. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI and for areas of future research, with the aim of improving understanding of the underlying processes and outcomes for patients with COVID-19 AKI.
Databáze: OpenAIRE
Externí odkaz: